About: Radiation Oncology in times of COVID-2019: A review article for those in the eye of the storm

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Radiation Oncology in times of COVID-2019: A review article for those in the eye of the storm – An Indian Perspective Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Radiation Oncology in times of COVID-2019: A review article for those in the eye of the storm – An Indian Perspective
Creator	Barthwal, Mansi George, Karishma Hinduja, Ritika Pareek, Vibhay
source	Elsevier; Medline; PMC
abstract	The global COVID-2019 pandemic has presented to the field of radiation oncology a management dilemma in providing evidence-based treatments to all cancer patients. There is a need for appropriate measures to be taken to reduce infectious spread between the medical healthcare providers and the patient population. Such times warrant resource prioritization and to continue treatment with best available evidence, thereby reducing the risk of COVID-2019 transmission in times where the workforce is reduced. There has been literature presented in different aspects related to providing safety measures, running of a radiation department and for the management of various cancer subsites. In this article, we present a comprehensive review for sustaining a radiation oncology department in times of the COVID-2019 pandemic.
has issue date	2020-07-13(xsd:dateTime)
bibo:doi	10.1053/j.seminoncol.2020.07.001
bibo:pmid	32819712
has license	no-cc
sha1sum (hex)	1c28eac5f830e72dc2465c9c62fa6576ed66b243
schema:url	https://doi.org/10.1053/j.seminoncol.2020.07.001
resource representing a document's title	Radiation Oncology in times of COVID-2019: A review article for those in the eye of the storm – An Indian Perspective
has PubMed Central identifier	PMC7357513
has PubMed identifier	32819712
schema:publication	Semin Oncol
resource representing a document's body	covid:1c28eac5f830e72dc2465c9c62fa6576ed66b243#body_text
is schema:about of	named entity 'healthcare' named entity 'patient' named entity 'genitourinary' named entity 'TO HELP' named entity 'accepted' named entity 'Details' named entity 'alternative' named entity 'pandemic' named entity 'services' named entity '2019' named entity 'transmission of disease' named entity 'radiotherapy' named entity 'review article' named entity 'palliative' named entity 'risk-benefit ratio' named entity 'COVID-2019' named entity 'Post-mastectomy' named entity 'Endometrial cancer' named entity 'hypofractionation' named entity 'palliative treatment' named entity 'EBRT' named entity 'radiation oncology' named entity 'cardiac toxicity' named entity 'immunocompromised' named entity 'endoscopic procedures' named entity 'SBRT' named entity 'Rotte' named entity 'chemotherapy' named entity 'Mumbai' named entity 'clinical trial' named entity 'MRI' named entity 'breast cancer' named entity 'prostate cancer' named entity 'Oncological' named entity 'comorbidities' named entity 'infection' named entity 'India' named entity 'successful treatment' named entity 'breast cancer' named entity 'chest wall' named entity 'brachytherapy' named entity 'evidence-based practice' named entity 'COVID-19' named entity 'brachytherapy' named entity 'pandemics' named entity 'external beam radiation therapy' named entity 'Genitourinary' named entity 'tumor' named entity 'infiltrating ductal carcinoma' named entity 'brachytherapy' named entity 'Radiation therapy' named entity 'radiotherapy' named entity 'SBRT' named entity 'CERVICAL CANCER' named entity 'radiation therapy' named entity 'oncological' named entity 'COVID-19 pandemic' named entity 'mode of transmission' named entity 'EBRT' named entity 'PPE' named entity 'radiotherapy' named entity 'external beam radiation therapy' named entity 'neoadjuvant chemotherapy' named entity 'breathlessness' named entity 'post-mastectomy' named entity 'radiation therapy' named entity 'chemotherapy' named entity 'radiotherapy' named entity 'CBCT' named entity 'levonorgestrel' named entity 'oncology' named entity 'SBRT' named entity 'brachytherapy' named entity 'ADT' named entity 'simple model' named entity 'phase II trials' named entity 'radiotherapy' named entity 'social distancing'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software